Victory Capital Management
HZNP

Victory Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Victory Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-107,004
Closed -$12.4M – 2693
2023
Q3 		$12.4M Sell
107,004
-16,534
-13% -$1.78M 0.01% 930
2023
Q2 		$12.7M Buy
123,538
+1,255
+1% +$132K 0.01% 950
2023
Q1 		$13.3M Sell
122,283
-39,147
-24% -$4.33M 0.02% 935
2022
Q4 		$18.4M Buy
161,430
+10,448
+7% +$868K 0.02% 806
2022
Q3 		$9.34M Sell
150,982
-459,973
-75% -$32.1M 0.01% 1080
2022
Q2 		$48.7M Sell
610,955
-24,600
-4% -$2.33M 0.06% 480
2022
Q1 		$65.1M Sell
635,555
-501,355
-44% -$48.9M 0.07% 419
2021
Q4 		$123M Sell
1,136,910
-82,823
-7% -$9.04M 0.11% 217
2021
Q3 		$134M Sell
1,219,733
-36,673
-3% -$3.81M 0.13% 182
2021
Q2 		$118M Sell
1,256,406
-161,070
-11% -$14.8M 0.11% 224
2021
Q1 		$130M Buy
1,417,476
+249,722
+21% +$21.1M 0.13% 187
2020
Q4 		$85.4M Sell
1,167,754
-296,499
-20% -$22M 0.1% 314
2020
Q3 		$114M Sell
1,464,253
-66,658
-4% -$4.59M 0.15% 185
2020
Q2 		$85.1M Sell
1,530,911
-1,477,965
-49% -$63.2M 0.12% 246
2020
Q1 		$89.1M Buy
3,008,876
+1,453,060
+93% +$49.2M 0.08% 376
2019
Q4 		$56.3M Buy
1,555,816
+704,566
+83% +$21.6M 0.07% 427
2019
Q3 		$23.2M Buy
851,250
+13,000
+2% +$336K 0.03% 744
2019
Q2 		$20.2M Sell
838,250
-208,395
-20% -$5.29M 0.04% 613
2019
Q1 		$27.7M Buy
+1,046,645
New +$24.8M 0.06% 478

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Victory Capital Management's HZNP Position: Q4 2023 in Review

Victory Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 107,004 shares — an estimated $12.4M sold.

Victory Capital Management first reported a position in HZNP in Q1 2019 and held it in 19 quarters. The position peaked at $134M in Q3 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Victory Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Victory Capital Management sold 107,004 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $12.4M.
  • Victory Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2019 and held it in 19 quarters.
  • Victory Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $134M in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Victory Capital Management's 13F filing for Q4 2023, filed 5 Feb 2024.